$10.16
-0.110 (-1.07%)
At Close: Jun 22, 2026
UiPath, Inc. $PATH Shares Sold by Fieldview Capital Management LLC
04:23am, Wednesday, 11'th Mar 2026
Fieldview Capital Management LLC lowered its stake in UiPath, Inc. (NYSE: PATH) by 91.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 29,843 shares of
US Stocks Mixed Amid Trump's End-Of-War Signals: Investor Fear Eases Slightly, Greed Index Remains In 'Fear' Zone
02:41am, Wednesday, 11'th Mar 2026
The CNN Business Fear and Greed Index measures market sentiment based on 7 indicators. Current reading of 27.9 puts it in 'Fear' zone.
Oracle, Campbell's And 3 Stocks To Watch Heading Into Wednesday
02:34am, Wednesday, 11'th Mar 2026
U.S. stock futures up, investors focusing on Campbell's, Oracle, UiPath earnings. Domo shares rise 39.3% in after-hours trading.
UiPath Achieves AIUC-1 Certification, Setting New Standard for AI Agent Security and Reliability
04:30pm, Monday, 09'th Mar 2026
NEW YORK--(BUSINESS WIRE)--UiPath becomes first enterprise automation platform to achieve AIUC-1 certification.
Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?
11:41am, Monday, 09'th Mar 2026
PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.
Stay Ahead of the Game With UiPath (PATH) Q4 Earnings: Wall Street's Insights on Key Metrics
10:15am, Friday, 06'th Mar 2026
Evaluate the expected performance of UiPath (PATH) for the quarter ended January 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics f
154,404 Shares in UiPath, Inc. $PATH Acquired by DNB Asset Management AS
04:18am, Wednesday, 04'th Mar 2026
DNB Asset Management AS bought a new stake in shares of UiPath, Inc. (NYSE: PATH) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Com
UiPath: Why Claude-Related Fears Are Grossly Overblown (Earnings Preview)
09:44am, Tuesday, 03'rd Mar 2026
UiPath, Inc. remains attractively valued after a 24% price drop, with macro and Claude-related fears appearing overblown given recent financial performance. PATH posted Q3 YoY revenue growth of ~16%,
UiPath's Debt-Free Balance Sheet Fuels Strategic Flexibility
02:45pm, Friday, 27'th Feb 2026
PATH's debt-free balance sheet and $1.4B cash reserve give it unique flexibility to invest boldly in automation growth.
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 27'th Feb 2026
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Market Today, Feb. 26: UiPath Advances as It Moves to Shape Agentic AI Standards
05:30pm, Thursday, 26'th Feb 2026
Expand NYSE: PATH UiPath Today's Change (7.80%) $0.78 Current Price $10.71 Key Data Points Market Cap $5.3B Day's Range $10.10 - $10.78 52wk Range $9.38 - $19.84 Volume 1.3M Avg Vol 29M Gross Margin 8
Prediction: Agentic AI Will Be the Biggest Tech Trend of 2026. Here Are 2 Stocks to Own
07:30pm, Tuesday, 24'th Feb 2026
ServiceNow has been growing its revenue quickly and has a big potential driver with its Control Tower solution. UiPath's stock is very cheap, and it has a huge potential opportunity in AI agent orches
UiPath Joins Agentic AI Foundation (AAIF) to Advance Interoperability in Agentic AI Adoption
04:30pm, Tuesday, 24'th Feb 2026
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has joined the Agentic AI Foundation (AAIF) as a Gold Member. Together with other member organ
40% of Enterprise Apps Will Embed AI Agents by End of 2026, According to Gartner. Here's How to Profit.
12:53pm, Tuesday, 24'th Feb 2026
The agentic AI market could expand significantly this year. UiPath's software robots are evolving into more intelligent AI agents.
Coherent vs. UiPath: Which AI Growth Stock Is the Better Buy?
12:10pm, Tuesday, 24'th Feb 2026
AI-fueled growth, surging revenues and bold partnerships set up a showdown, but which stock among COHR and PATH has the stronger edge? Read on to find out.
Sign In
Buy PATH